Together, the KI/KO mouse model recapitulates important clinical aspects of Catel–Manzke syndrome, corroborates the biochemical function of TGDS and provides evidence that a functional UXS1 deficiency might underlie the clinical phenotype. Here, TGDS is linked to Catel-Manzke syndrome.